Carnitor (Levocarnitine) - Summary

CARNITOR SUMMARY

CARNITOR® (levocarnitine) is a carrier molecule in the transport of long-chain fatty acids across the inner mitochondrial membrane.

For the acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency.

For the prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. (US Patent Nos. 6,335,369; 6,429,230; 6,696,493)

CARNITOR NEWS HIGHLIGHTS

Published Studies Related to Carnitor (Levocarnitine)

Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. [2003]

Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. [1992.11]

more>>

Clinical Trials Related to Carnitor (Levocarnitine)

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy [Completed]

Ability of L-Carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy [Recruiting]

Carnitine Levels and Carnitine Supplementation in Type I Diabetes [Recruiting]

Early Administration of L-Carnitine in Hemodialysis Patients [Recruiting]

Levocarnitine in Treating Fatigue in Cancer Patients [Completed]

more>>